Research ExplorerPublicationsExpression levels of Activated Leukocyte Cell Adhesion Molec...

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

Standard

Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. / Henningsen, Maike; Köhler, N; Kersten, Jan Felix; Milde-Langosch, Karin; Beck, K; Höller, S; Müller, Volkmar; Witzel, Isabell; Jänicke, Fritz; Kilic, E.

In: DIS MARKERS, Vol. 28, No. 2, 2, 2010, p. 71-78.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Henningsen, M, Köhler, N, Kersten, JF, Milde-Langosch, K, Beck, K, Höller, S, Müller, V, Witzel, I, Jänicke, F & Kilic, E 2010, 'Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.', DIS MARKERS, vol. 28, no. 2, 2, pp. 71-78. https://doi.org/10.3233/DMA-2010-0685

APA

Henningsen, M., Köhler, N., Kersten, J. F., Milde-Langosch, K., Beck, K., Höller, S., Müller, V., Witzel, I., Jänicke, F., & Kilic, E. (2010). Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. DIS MARKERS, 28(2), 71-78. [2]. https://doi.org/10.3233/DMA-2010-0685

Vancouver

Henningsen M, Köhler N, Kersten JF, Milde-Langosch K, Beck K, Höller S et al. Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases. DIS MARKERS. 2010;28(2):71-78. 2. https://doi.org/10.3233/DMA-2010-0685

Bibtex

@article{a358753137df4769ab66c17f788cc4f4,
title = "Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.",
abstract = "Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.",
author = "Maike Henningsen and N K{\"o}hler and Kersten, {Jan Felix} and Karin Milde-Langosch and K Beck and S H{\"o}ller and Volkmar M{\"u}ller and Isabell Witzel and Fritz J{\"a}nicke and E Kilic",
year = "2010",
doi = "10.3233/DMA-2010-0685",
language = "Deutsch",
volume = "28",
pages = "71--78",
journal = "DIS MARKERS",
issn = "0278-0240",
publisher = "IOS Press",
number = "2",

}

RIS

TY - JOUR

T1 - Expression levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in primary breast carcinoma and distant breast cancer metastases.

AU - Henningsen, Maike

AU - Köhler, N

AU - Kersten, Jan Felix

AU - Milde-Langosch, Karin

AU - Beck, K

AU - Höller, S

AU - Müller, Volkmar

AU - Witzel, Isabell

AU - Jänicke, Fritz

AU - Kilic, E

PY - 2010

Y1 - 2010

N2 - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.

AB - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) gained increasing attention regarding tumorprogression and metastatic spread in breast cancer. The aim of this study was to examine ALCAM expression levels in primary breast cancer and distant metastases of the same patient within 29 autopsy cases to better understand the underlying mechanisms of metastases and the role of adhesion molecules in this process.

U2 - 10.3233/DMA-2010-0685

DO - 10.3233/DMA-2010-0685

M3 - SCORING: Zeitschriftenaufsatz

VL - 28

SP - 71

EP - 78

JO - DIS MARKERS

JF - DIS MARKERS

SN - 0278-0240

IS - 2

M1 - 2

ER -